Stock Runners : Regulus Therapeutics Inc. (NASDAQ:RGLS), American Airlines Group Inc. (NASDAQ:AAL), H&R Block, Inc. (NYSE:HRB), Allergan Inc. (NYSE:AGN), Marine Products (NYSE:MPX)

Regulus Therapeutics Inc. (NASDAQ:RGLS) announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell approximately $80,000,000 of shares of its common stock, of which approximately $70,000,000 of shares are being offered by Regulus and approximately $10,000,000 of shares are being offered by an existing stockholder of Regulus, Isis Pharmaceuticals, Inc. Regulus Therapeutics Inc. (NASDAQ:RGLS) belongs to … Continue reading Stock Runners : Regulus Therapeutics Inc. (NASDAQ:RGLS), American Airlines Group Inc. (NASDAQ:AAL), H&R Block, Inc. (NYSE:HRB), Allergan Inc. (NYSE:AGN), Marine Products (NYSE:MPX)

ResMed Sees Impressive Growth in Q3

ResMed delivered another impressive performance in the third quarter of fiscal 2013. Revenue rose 10% to USD 384 million, operating income increased 26% to USD 96.1 million and net income was 31% higher at USD 84.9 million. Diluted earnings per share rose 32% to USD 0.58 and over the nine months to 31 March 2013 are 36% higher than in the corresponding nine months in … Continue reading ResMed Sees Impressive Growth in Q3